GNH USA

Europe — EMA

Migard (Frovatriptan)

GNH USA supplies Migard (Frovatriptan), a Triptan for acute treatment of migraine attacks. Request a quote for worldwide supply to hospitals and pharmacies.

Frovatriptan

Request sourcing

1
Pack/s

What is Frovatriptan?

Frovatriptan, the active ingredient in Migard, is a Triptan (5‑HT1B/1D receptor agonist) presented as an oral tablet for oral use. It provides rapid relief of migraine headache pain and associated symptoms in adult patients. The product conforms to European Union regulatory standards and is manufactured under GMP conditions.

GNH USA supplies Migard as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide with a focus on quality and regulatory compliance.

What is Frovatriptan used for?

Frovatriptan is a triptan medication indicated for the acute treatment of migraine.

Migraine attack (with or without aura): provides rapid relief of headache pain and associated symptoms when taken at onset. Migraine with aura: reduces severity of aura and subsequent headache. Menstrual migraine (short‑term prophylaxis): may be used to prevent migraine attacks linked to the menstrual cycle.

What are the side effects of Frovatriptan?

Common Side Effects: - Nausea: mild to moderate stomach upset. - Dizziness: transient feeling of light‑headedness. - Fatigue: unusual tiredness after dosing. - Dry mouth: reduced salivation. - Somnolence: mild sleepiness. - Chest discomfort: sensation of tightness or pressure.

Serious or Rare Side Effects: - Coronary vasospasm: chest pain due to reduced coronary blood flow. - Serotonin syndrome: agitation, hyperthermia, and neuromuscular abnormalities when combined with serotonergic agents.

What precautions apply to Frovatriptan?

Before using Migard, consider the following precautions: - Cardiovascular assessment: evaluate history of ischemic heart disease or uncontrolled hypertension. - Contraindication with ergot derivatives: avoid concurrent use to prevent excessive vasoconstriction. - Caution with serotonergic drugs: monitor for signs of serotonin syndrome. - Hepatic impairment: dose adjustment may be required in patients with liver dysfunction. - Pregnancy and lactation: use only if the potential benefit justifies the potential risk. - Store at room temperature: keep in the original packaging, protect from moisture and direct sunlight.

What does Frovatriptan interact with?

Frovatriptan may interact with several drug classes.

Major Interactions (Avoid): - Ergot alkaloids: combined vasoconstriction can precipitate serious cardiovascular events. - Monoamine oxidase inhibitors (MAOIs): increased risk of serotonin syndrome. - Other triptans: additive vasoconstrictive effects may be hazardous.

Moderate Interactions (Monitor Closely): - SSRIs/SNRIs: potential for serotonin syndrome; monitor patient closely. - Beta‑blockers: may increase plasma concentrations of frovatriptan. - Strong CYP3A4 inhibitors (e.g., ketoconazole): can raise frovatriptan exposure, requiring dose consideration.

Frequently asked questions

What is Migard used for?+
Migard contains frovatriptan, a triptan class medication used for the acute treatment of migraine attacks in adults. It helps relieve headache pain and associated symptoms such as nausea, photophobia, and phonophobia when taken at the onset of an attack.
How does frovatriptan work?+
Frovatriptan works by binding to serotonin 5‑HT1B and 5‑HT1D receptors on cranial blood vessels and trigeminal nerve endings. This binding causes vasoconstriction of dilated intracranial arteries and blocks the release of inflammatory neuropeptides, interrupting the pain pathway that triggers migraine.
What is the usual dose of Migard?+
The appropriate dose of Migard is determined by a qualified prescriber based on the individual patient's clinical condition, response, and any relevant medical history. Patients should follow the prescribing information provided by their healthcare professional.
Is Migard safe during pregnancy or breastfeeding?+
The safety of frovatriptan in pregnancy or while breastfeeding has not been definitively established. It should only be used if the potential benefit to the mother outweighs any possible risk to the fetus or infant, and after discussion with a healthcare provider.
How do I order Migard from GNH USA?+
To order Migard, submit an enquiry on the product page at gnh-usa.com specifying the required quantity. GNH USA works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.
How does Migard compare with other migraine treatments?+
Migard (frovatriptan) is a long‑acting triptan, offering a slower onset but a prolonged duration of action compared with faster‑acting triptans such as sumatriptan. This profile can be advantageous for migraine attacks that tend to recur or last longer, while still providing the same mechanism of vasoconstriction and pain relief.
What are the storage requirements for Migard?+
Migard should be stored at room temperature, below 25 °C. Keep the tablets in the original blister pack or container, protect them from moisture and direct sunlight, and ensure they are out of reach of children.
How is Migard administered?+
Migard is taken orally, usually as a single tablet at the first sign of a migraine attack. The tablet should be swallowed whole with water and not crushed or chewed. If the migraine recurs, a second dose may be considered after a minimum interval as advised by a physician.
What are the most serious risks associated with Migard?+
The most serious risks include coronary vasospasm, which can cause chest pain or heart attack, and serotonin syndrome, a potentially life‑threatening condition that may occur when combined with other serotonergic agents. Patients should seek immediate medical attention if they experience severe chest discomfort or symptoms of serotonin excess.
Who should not use Migard?+
Migard is contraindicated in patients with a history of ischemic heart disease, uncontrolled hypertension, severe hepatic impairment, or known hypersensitivity to frovatriptan or any other triptan. It should also be avoided in individuals currently taking ergot alkaloids or monoamine oxidase inhibitors.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.
Send a sourcing enquiry for this product →

Product details

Drug
Frovatriptan
Route
Oral Use
Manufacturer
Menarini International Operations Luxembourg S.A.
Origin
EU

Related products

Allegro

Allegro

Frovatriptan

Berlin-Chemie Ag
EU
Auradol

Auradol

Frovatriptan

Istituto Luso Farmaco D'italia S.P.A.
EU
Dorlise

Dorlise

Frovatriptan

Menarini International Operations Luxembourg S.A.
EU
Eumitan

Eumitan

Frovatriptan

Menarini International Operations Luxembourg S.A.
EU